ICAAC 46th

Drupal spam blocked by CleanTalk.
Title Content type
Effect of Antifungals on Release of (1-3)-àŸ-Glucan by Aspergillus fumigatus. (click for details)
BAL4815, a New Antifungal Agent: Determination of Quality Control Limits for Susceptibility Testing by Methods of the European Committee on Antimicrobial Susceptibility Testing (EUCAST). (click for details)
3M-003, An Agonist Of Toll-like Receptors (TLRs) 7 And 8, Significantly Upregulates Effector Cell Anti-fungal Activity. (click for details)
Efficacy of Micafungin in Experimental Hematogenous Candida Meningoencephalitis: 1,3-946;-D-Glucan as a Surrogate Marker for Detection and Therapeutic Response. (click for details)
Molecular Characterization of Cyp51A and B Genes From Voriconazole-Resistant and -Susceptible Isolates of Aspergillus Flavus. (click for details)
In Vitro Activity of Posaconazole Compared with Seven Antifungal Agents against 80 Clinical and 15 Environmental Isolates of Exophiala Dermatitidis. (click for details)
Prospective, Multicenter Study of Caspofungin (CAS) for Prophylaxis in High Risk Liver Transplantation (LT). (click for details)
Body Mass Index (BMI) Significantly Increased with Macrolide Treatment in Patients with Chronic Necrotizing Pulmonary Aspergillosis. (click for details)
Activity In Vitro of 27 Combinations of Licensed Antifungal Agents against Scedosporium apiospermum (Sa) and Scedosporium prolificans (Sp). (click for details)
Impact of a Caspofungin (CAS) Restriction Policy on Appropriateness of Use and the Financial Implications in a Large Tertiary Hospital. (click for details)


Subscribe to ICAAC 46th